Article Versions Notes

Elbadawi M, Boulos JC, Dawood M, Zhou M, Gul W, ElSohly MA, Klauck SM, Efferth T. The Novel Artemisinin Dimer Isoniazide ELI-XXIII-98-2 Induces c-MYC Inhibition, DNA Damage, and Autophagy in Leukemia Cells. Pharmaceutics. 2023; 15(4):1107. https://doi.org/10.3390/pharmaceutics15041107

Elbadawi, Mohamed, Joelle C. Boulos, Mona Dawood, Min Zhou, Waseem Gul, Mahmoud A. ElSohly, Sabine M. Klauck, and Thomas Efferth. 2023. "The Novel Artemisinin Dimer Isoniazide ELI-XXIII-98-2 Induces c-MYC Inhibition, DNA Damage, and Autophagy in Leukemia Cells" Pharmaceutics 15, no. 4: 1107. https://doi.org/10.3390/pharmaceutics15041107

Elbadawi, M., Boulos, J. C., Dawood, M., Zhou, M., Gul, W., ElSohly, M. A., Klauck, S. M., & Efferth, T. (2023). The Novel Artemisinin Dimer Isoniazide ELI-XXIII-98-2 Induces c-MYC Inhibition, DNA Damage, and Autophagy in Leukemia Cells. Pharmaceutics, 15(4), 1107. https://doi.org/10.3390/pharmaceutics15041107